Process for obtaining high efficiency human albumin for use in detoxification therapy
View Patent ↗A process for detoxifying the blood of a patient in need thereof involves: collecting albumin from human plasma and/or plasma fractions; diafiltration of a mixture containing the collected albumin; stabilizing the resulting diafiltered albumin mixture with sodium chloride and an amino acid in the absence of any added fatty acid; pasteurizing the stabilized albumin mixture; diafiltering the pasteurized mixture to remove, among other things, stabilizers; and detoxifying the blood of the patient by administering the resulting albumin to the patient. In one embodiment, the amino acid stabilizing agent is acetyl tryptophan. The resulting albumin has at least about 80% albumin binding capacity relative to natural plasma albumin, and is storage stable for about 30 months at 30° C.
1. A method for detoxifying the blood of a patient in need thereof comprising:
(1) collecting an albumin-containing fraction from human plasma;
(2) subjecting said albumin-containing fraction to diafiltration;
(3) stabilizing the diafiltered albumin fraction with effective amounts of NaCl and one or more amino acids and in the absence of any added fatty acids;
(4) pasteurizing the stabilized albumin fraction;
(5) subjecting the pasteurized albumin fraction to diafiltration, said diafiltration is carried out such that the resulting albumin retains at least 80% albumin binding capacity during storage for 30 months at 30° C.±2° C.; and
(6) detoxification of the blood of said patient by administering the albumin resulting from step (5) to the patient.
2. The method of claim 1 , wherein the albumin is administered to the patient by infusion.
3. The method of claim 1 , wherein the albumin is administered to the patient by plasmapheresis.
4. The method of claim 1 , wherein the albumin is administered to the patient in combination with the blood of the patient in an extracorporeal system.